BioSyent Signs Exclusive Product Development, Supply and Distribution Agreement

BioSyent has signed an exclusive product development, supply and distribution agreement with a new partner for a new product under its Hospital Products Division.

Reportedly, the product will be launched after Health Canada approval. The agreement represents the second new partner, with whom BioSyent has signed an agreement in the last two months.

BioSyent continues to concentrate on its pharmaceutical strategy to source products that have been successfully developed and proven to be safe and effective, manage these products through the regulatory process and product registration (approval). Once approved, the company plans to market these products in Canada.

BioSyent is a publicly traded specialty pharmaceutical company, which sources, acquires or in-licences pharmaceutical products and markets these products in Canada.